NCT01582399View on ClinicalTrials.gov

Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Pharmacokinetics of ASKP1240Pharmacodynamics of ASKP1240Healthy Volunteers

Interventions

DRUG

ASKP1240

intravenous(IV) infusion and subcutaneous (SC)

Trial Locations (1)

21225

Parexel, Baltimore

All Listed Sponsors

collaborator

Kyowa Kirin Co., Ltd.

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT01582399 - Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240 | Biotech Hunter | Biotech Hunter